People with treatment resistant depression are more likely to suffer injury or death than those who are well treated for their depression. A study from the Journal of Affective disorders showed that patients with treatment resistant depression have a 35% higher rate of death from all causes.
An experimental nasal spray, which has a compound similar to the "club drug" ketamine, has been recommended as a new depression treatment by an advisory panel to the Food and Drug Administration Tuesday.
An experimental nasal spray, which has a compound similar to the "club drug" ketamine, has been recommended as a new depression treatment by an advisory panel to the Food and Drug Administration Tuesday.